Chapel hill.

PositionTriangle

CHAPEL HILL -- Cempra Pharmaceuticals raised $46 million to test an antibiotic aimed at treating drug-resistant infections. Philadelphia-based Quaker BioVentures led the round, which included...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT